Q1 2025 Financial Performance - Net sales were $1.1 billion, a decrease of 21% compared to Q1 2024's $1.361 billion[13, 15] - Adjusted EBITDA was $267 million, down 8.3% year-over-year from $291 million in Q1 2024[13, 15] - Specialties and Ketjen segments saw year-over-year Adjusted EBITDA gains of 30% and 76%, respectively[13, 18] - Cash from operations reached $545 million, representing a 204% operating cash flow conversion, or 73% excluding a customer prepayment[13] - The company has line of sight to breakeven free cash flow in 2025[13] 2025 Outlook and Strategy - The company maintains its FY 2025 outlook, with ranges based on lithium market price scenarios[11] - Albemarle achieved approximately 90% run-rate against the midpoint of its $350 million cost and productivity improvement target through April and identified opportunities to reach the high-end of the $300 million to $400 million range[11] - The estimated FY 2025 capital expenditure is $700 million to $800 million, a decrease of over 50% year-over-year[30] Lithium Market Dynamics - Long-term lithium demand is expected to grow approximately 2x between 2024 and 2030, driven by electric vehicles and grid storage[14] - The company anticipates a direct tariff impact of approximately $30 million to $40 million in 2025, before mitigations[21] - Expected lithium demand growth is greater than 2x from 1.2 MMT LCE in 2024 to a range of 2.5 to 3.3 MMT LCE in 2030[43, 44]
Albemarle(ALB) - 2025 Q1 - Earnings Call Presentation